Pharmaceutical companies are embracing the challenge of sustainability, with heavy focus on how the industry can better engage, monitor, and improve their suppliers and contract manufacturers. It’s been realized and understood that across the industry Environment, Social, and Governance (ESG) management may face the greatest risk exposure in the supply chain.

BSI were one of the originally qualified PSCI audit firms, and have supported the further development of the PSCI requirements and the audit approach with the PSCI program itself.

Within the pharma industry, there’s been a trend in the adoption of the PSCI and its audit template, as the primary mechanism to assess and monitor environmental health and safety (EHS) and labour risks across their supplier base. Organizations are adopting the PSCI program in various guises and we’re working with the industry to ensure the adoption of the principles, while remaining agile and enabling a bespoke client-specific approach to deliver an EHS and labour audit on the supply chain.